Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT04006769
What this trial is testing

Entacapone Combination With Imatinib for Treatment of GIST

Who this might be right for
Gastrointestinal Stromal Tumor, Malignant
Xiangya Hospital of Central South University 5
Not applicableEnrolling By InvitationNCT07264296
What this trial is testing

Implant-Related Infections in Patients With Skeletal Sarcomas

Who this might be right for
Implant InfectionSkeletal SarcomaHip Arthritis+2 more
Vastra Gotaland Region 40
Testing effectiveness (Phase 2)Looking for participantsNCT06534762
What this trial is testing

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Who this might be right for
NSCLCSCLCColorectal Cancer+4 more
Zhejiang Provincial People's Hospital 260
Testing effectiveness (Phase 2)Study completedNCT01913652
What this trial is testing

Ph II Cabazitaxel DD Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
European Organisation for Research and Treatment of Cancer - EORTC 42
Not applicableLooking for participantsNCT07377747
What this trial is testing

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Who this might be right for
Retroperitoneal Liposarcoma
Australia and New Zealand Sarcoma Association 100
Large-scale testing (Phase 3)Study completedNCT02451943
What this trial is testing

Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 509
Testing effectiveness (Phase 2)Looking for participantsNCT06975293
What this trial is testing

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Who this might be right for
Solid TumorSarcomaLeiomyosarcoma+1 more
STORM Therapeutics LTD 107
Testing effectiveness (Phase 2)Study completedNCT00020449
What this trial is testing

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT04145349
What this trial is testing

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell Tumor
Eli Lilly and Company 30
Not applicableUnknownNCT03932058
What this trial is testing

Proteomics Research of Osteosarcoma

Who this might be right for
OsteosarcomaProteomics
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04784247
What this trial is testing

Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Sarcoma
Memorial Sloan Kettering Cancer Center 52
Testing effectiveness (Phase 2)Ended earlyNCT01061606
What this trial is testing

Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Who this might be right for
Recurrent Uterine SarcomaUterine Carcinosarcoma
National Cancer Institute (NCI) 8
Early research (Phase 1)Enrolling By InvitationNCT06674538
What this trial is testing

Clinical Trial to Treat Stage IV Cancer Patients

Who this might be right for
Soft Tissue Cancer
Moonshot Antibodies 12
Not applicableUnknownNCT02509234
What this trial is testing

Trabectedin and Irinotecan for Refractory Pediatric Sarcomas

Who this might be right for
Recurrent Childhood Soft Tissue SarcomaRecurrent Ewing SarcomaRecurrent Rhabdomyosarcoma
Technical University of Munich 30
Testing effectiveness (Phase 2)UnknownNCT01192633
What this trial is testing

Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma

Who this might be right for
SarcomaChemotherapy
Fudan University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT00840047
What this trial is testing

Methionine PET/CT Studies In Patients With Cancer

Who this might be right for
Brain Tumors and/or Solid Tumors IncludingBrain Stem GliomaHigh Grade CNS Tumors+11 more
St. Jude Children's Research Hospital 503
Large-scale testing (Phase 3)Not Yet RecruitingNCT07615049
What this trial is testing

Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation

Who this might be right for
Recurrent Soft Tissue Sarcoma of the Trunk and ExtremitiesResectable Soft Tissue Sarcoma of the Trunk and ExtremitiesSoft Tissue Sarcoma of the Trunk and Extremities+2 more
SWOG Cancer Research Network 296
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Early research (Phase 1)Ended earlyNCT05355753
What this trial is testing

Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

Who this might be right for
Synovial SarcomaSoft Tissue Sarcoma
C4 Therapeutics, Inc. 49
Not applicableStudy completedNCT04512495
What this trial is testing

Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?

Who this might be right for
Sarcoma
Institut Claudius Regaud 60
Next Page